Table 3.

Characteristics of 48 patients with metastatic prostate cancer

Variables	Median (range, mean ± SD)
Age (y)	70.5 (51–88, 71.33 ± 6.92)
Initial PSA (ng/mL)	82.16 (8.2–7285, 605.06 ± 1446.25)
Pathological Grade
Gleason Score ≤ 6	2 (4.2 %)
Gleason Score = 7	14 (29.2 %)
Gleason Score ≥ 8	32 (66.7 %)
Clinical T Stage
2	6 (12.5 %)
3	27 (56.3 %)
4	15 (31.3 %)
Clinical N Stage
0	21 (43.8 %)
1	27 (56.3 %)
Clinical M Stage
0	13 (27.1 %)
1	35 (72.9 %)
NLR	2.49 (0.84–10.56, 2.93 ± 1.66)